# Inflammatory Markers Dynamics in Response to Extra-corporeal Membrane Oxygenator Decannulation

> **NCT04678518** · NA · UNKNOWN · sponsor: **Hamad Medical Corporation** · enrollment: 30 (estimated)

## Conditions studied

- Inflammatory Markers Changes in Response to Extra-corporeal Membrane Oxygenator Decannulation

## Interventions

- **DIAGNOSTIC_TEST:** Inflammatory makers that will include Interleukins (IL); IL1, IL2, IL6 and TNF

## Key facts

- **NCT ID:** NCT04678518
- **Lead sponsor:** Hamad Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02-28
- **Primary completion:** 2023-10-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-05-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04678518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04678518, "Inflammatory Markers Dynamics in Response to Extra-corporeal Membrane Oxygenator Decannulation". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04678518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*